Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20242003
Brunno Santos de Freitas Silva, Reuber Mendes Rocha, Tiago Paiva Prudente, Milena Moraes de Oliveira Lenza, Daniel Lobato Ferreira Ferraz, Eleazar Mezaiko, Francine Do Couto Lima Moreira, F. P. Yamamoto-Silva
Background: Potentially malignant oral disorders (PMOD) play a vital role in the secondary prevention of oral cancer, especially considering the difficulty in identifying specific risk factors. Oral leukoplakia (OL), the most common PMOD, has a variable malignant transformation rate. Photodynamic therapy (PDT) emerges as a promising alternative in treating these conditions. This approach is particularly valuable for extensive lesions or patients with contraindications to conventional treatments. Despite promising results, the choice of photosensitizer agent still lacks consensus. The aim of this study is to evaluate the efficacy of PDT with 5% methylene blue compared to 20% aminolevulinic acid (ALA) in the treatment of OL. Methods: This is a randomized, controlled, double-blind clinical trial with a non-inferiority testing approach. Patients will be allocated into two groups: leukoplakia experimental group (PDT with methylene blue) and leukoplakia control group (PDT with ALA). The analysis of results will be based on primary outcomes (clinical remission) and secondary outcomes (histological/cytological worsening, lesion appearance, symptoms, function, psychological impact, economic impact, treatment adherence, and adverse effects). Allocation will be performed in a randomized and stratified manner, ensuring equivalence between groups. Cost-effectiveness analysis will consider the direct costs of treatment from both professional and patient perspectives. Conclusions: This study aims to contribute to the establishment of an effective, safe, and accessible treatment protocol for the most prevalent PMOD, filling an important gap in the scientific literature and providing guidelines for future clinical practices.
背景：潜在恶性口腔疾病（PMOD）在口腔癌的二级预防中起着至关重要的作用，特别是考虑到很难确定具体的风险因素。口腔白斑病（OL）是最常见的恶性口腔疾病，其恶性转化率各不相同。光动力疗法（PDT）是治疗这些病症的一种很有前途的替代疗法。这种方法对于大面积病变或有传统治疗禁忌症的患者尤为重要。尽管效果良好，但对光敏剂的选择仍缺乏共识。本研究旨在评估 5%亚甲基蓝光化学疗法与 20% 氨基乙酸（ALA）光化学疗法治疗 OL 的疗效：这是一项随机、对照、双盲临床试验，采用非劣效性测试方法。患者将被分为两组：白斑病实验组（亚甲蓝 PDT）和白斑病对照组（ALA PDT）。结果分析将基于主要结果（临床缓解）和次要结果（组织学/细胞学恶化、病变外观、症状、功能、心理影响、经济影响、治疗依从性和不良反应）。将以随机和分层的方式进行分配，确保各组之间的等效性。成本效益分析将从专业人员和患者的角度考虑治疗的直接成本：本研究旨在为最常见的 PMOD 建立一个有效、安全、易行的治疗方案，填补科学文献中的一个重要空白，并为未来的临床实践提供指导。
{"title":"Efficacy of 5% methylene blue photodynamic therapy in the treatment of potentially malignant oral disorders: a randomized, double-blind, controlled trial","authors":"Brunno Santos de Freitas Silva, Reuber Mendes Rocha, Tiago Paiva Prudente, Milena Moraes de Oliveira Lenza, Daniel Lobato Ferreira Ferraz, Eleazar Mezaiko, Francine Do Couto Lima Moreira, F. P. Yamamoto-Silva","doi":"10.18203/2349-3259.ijct20242003","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242003","url":null,"abstract":"Background: Potentially malignant oral disorders (PMOD) play a vital role in the secondary prevention of oral cancer, especially considering the difficulty in identifying specific risk factors. Oral leukoplakia (OL), the most common PMOD, has a variable malignant transformation rate. Photodynamic therapy (PDT) emerges as a promising alternative in treating these conditions. This approach is particularly valuable for extensive lesions or patients with contraindications to conventional treatments. Despite promising results, the choice of photosensitizer agent still lacks consensus. The aim of this study is to evaluate the efficacy of PDT with 5% methylene blue compared to 20% aminolevulinic acid (ALA) in the treatment of OL.\u0000Methods: This is a randomized, controlled, double-blind clinical trial with a non-inferiority testing approach. Patients will be allocated into two groups: leukoplakia experimental group (PDT with methylene blue) and leukoplakia control group (PDT with ALA). The analysis of results will be based on primary outcomes (clinical remission) and secondary outcomes (histological/cytological worsening, lesion appearance, symptoms, function, psychological impact, economic impact, treatment adherence, and adverse effects). Allocation will be performed in a randomized and stratified manner, ensuring equivalence between groups. Cost-effectiveness analysis will consider the direct costs of treatment from both professional and patient perspectives.\u0000Conclusions: This study aims to contribute to the establishment of an effective, safe, and accessible treatment protocol for the most prevalent PMOD, filling an important gap in the scientific literature and providing guidelines for future clinical practices.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"43 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141805429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20241998
Keramettin Yanık, Atakan Özkan
Background: This study aims to examine B12 levels in general in our society, to determine the rates of B12 deficiency, and to determine and recommend new B12 reference range values according to current data. Methods: A total of 16497 patients who were admitted to our secondary care hospital for various reasons in the three-year period between January 2021 and December 2023 and whose B12 levels were tested in their serum were included in the study. B12 levels of all patients were measured in the hospital biochemistry laboratory on Architect i1000SR and i2000 SR (Abbott diagnostics, Ireland) devices. Results: The reference ranges for B12 levels, determined as 2.5% and 97.5%, were 130-1084 pg/ml for adult men, and as 137-993 pg/ml for adult women. Considering 200 pg/ml as the normal lower limit for B12 level, low levels were found in 14.6% of all patients. Conclusions: Our study is one of the rare studies in which B12 reference ranges are investigated up-to-date with a large patient participation. Our findings showed that the rate of B12 deficiency in the society is very high compared to the generally accepted reference lower limit values, that B12 levels in the society are very low compared to these reference values, and perhaps that the reference lower limit values may need to be reduced to 149-138 pg/ml in individuals under 18 years of age, 130-137 pg/ml in adults, and 123-125 pg/ml in the elderly.
{"title":"B12 deficiency epidemic? Should B12 level lower limit reference values be decreased?","authors":"Keramettin Yanık, Atakan Özkan","doi":"10.18203/2349-3259.ijct20241998","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20241998","url":null,"abstract":"Background: This study aims to examine B12 levels in general in our society, to determine the rates of B12 deficiency, and to determine and recommend new B12 reference range values according to current data.\u0000Methods: A total of 16497 patients who were admitted to our secondary care hospital for various reasons in the three-year period between January 2021 and December 2023 and whose B12 levels were tested in their serum were included in the study. B12 levels of all patients were measured in the hospital biochemistry laboratory on Architect i1000SR and i2000 SR (Abbott diagnostics, Ireland) devices.\u0000Results: The reference ranges for B12 levels, determined as 2.5% and 97.5%, were 130-1084 pg/ml for adult men, and as 137-993 pg/ml for adult women. Considering 200 pg/ml as the normal lower limit for B12 level, low levels were found in 14.6% of all patients.\u0000Conclusions: Our study is one of the rare studies in which B12 reference ranges are investigated up-to-date with a large patient participation. Our findings showed that the rate of B12 deficiency in the society is very high compared to the generally accepted reference lower limit values, that B12 levels in the society are very low compared to these reference values, and perhaps that the reference lower limit values may need to be reduced to 149-138 pg/ml in individuals under 18 years of age, 130-137 pg/ml in adults, and 123-125 pg/ml in the elderly.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"34 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141806003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20242002
Rachel Buhagiar, Kristina Bettenzana, Jane Barlow
Background: The literature strongly suggests that early parent-child relational interventions for at-risk dyads can support healthy infant development and attachment security. Video Feedback (VF) is a widely used attachment-based intervention, but evidence for its effectiveness with mother-baby dyads where there is maternal psychopathology remains limited. Methods: This study constitutes a two-armed pilot randomised controlled trial aimed at evaluating the feasibility, acceptability, and preliminary benefits of Video Interaction Guidance (VIG), a type of VF, on mother-child dyadic interactional quality for postpartum women and their infants in Malta. Participants must be mothers with a baby aged 0-12 months who meet criteria for one or more mental health disorders on diagnostic interview. Exclusions are severe maternal mental illness, active drug dependence, being in receipt of in-patient care or therapy, or inability to speak English or Maltese. Consenting, eligible mothers are randomly allocated (minimised by infant age, relationship and employment status, and number of children at home), to either 3 cycles of one-to-one VIG intervention and treatment-as-usual (TAU), or to TAU only. Outcome assessors are blind to study arm allocation. The primary outcomes are parental sensitivity and dyadic synchrony coded using the CARE-index. Secondary outcomes are maternal depression and anxiety, bonding experience, capacity for reflective functioning, and well-being. Conclusions: This is the first study on the preliminary effectiveness of VIG within perinatal services in Malta. Findings should guide future larger scale, definitive RCTs and subsequently inform health policy and management decisions in perinatal and infant mental health care. Trial registration: Registered 16th March 2023 in ISRCTN registry (Trial ID: ISRCTN26320951).
{"title":"The effectiveness of video feedback intervention on mother-infant interactional quality for women with perinatal mental health illnesses: protocol for a pilot randomised control trial","authors":"Rachel Buhagiar, Kristina Bettenzana, Jane Barlow","doi":"10.18203/2349-3259.ijct20242002","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242002","url":null,"abstract":"Background: The literature strongly suggests that early parent-child relational interventions for at-risk dyads can support healthy infant development and attachment security. Video Feedback (VF) is a widely used attachment-based intervention, but evidence for its effectiveness with mother-baby dyads where there is maternal psychopathology remains limited.\u0000Methods: This study constitutes a two-armed pilot randomised controlled trial aimed at evaluating the feasibility, acceptability, and preliminary benefits of Video Interaction Guidance (VIG), a type of VF, on mother-child dyadic interactional quality for postpartum women and their infants in Malta. Participants must be mothers with a baby aged 0-12 months who meet criteria for one or more mental health disorders on diagnostic interview. Exclusions are severe maternal mental illness, active drug dependence, being in receipt of in-patient care or therapy, or inability to speak English or Maltese. Consenting, eligible mothers are randomly allocated (minimised by infant age, relationship and employment status, and number of children at home), to either 3 cycles of one-to-one VIG intervention and treatment-as-usual (TAU), or to TAU only. Outcome assessors are blind to study arm allocation. The primary outcomes are parental sensitivity and dyadic synchrony coded using the CARE-index. Secondary outcomes are maternal depression and anxiety, bonding experience, capacity for reflective functioning, and well-being.\u0000Conclusions: This is the first study on the preliminary effectiveness of VIG within perinatal services in Malta. Findings should guide future larger scale, definitive RCTs and subsequently inform health policy and management decisions in perinatal and infant mental health care. \u0000Trial registration: Registered 16th March 2023 in ISRCTN registry (Trial ID: ISRCTN26320951).","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"4 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20242000
Namra A. Sayed, Yashashri Shetty, S. Salgaonkar
Background: Diabetes poses an additional risk during anesthesia, yet there is a lack of sufficient Indian data on perioperative antidiabetic drug use and its implications. This droves us to conduct the study. Methods: Cross-sectional, observational study, conducted in a tertiary care hospital's general surgery and orthopaedics wards. Data collected from the first anaesthetist visit to 24 hours postoperative period included antidiabetic medications, anesthesia drugs, blood sugar levels, co-morbidities, concomitant medications, and intravenous (IV) fluids. Descriptive statistics and parametric tests were used for analysis. Results: The study comprised 180 patients (62.8% males, median age 56 years), with diabetes duration predominantly between 1-5 years (28.3%). Preoperatively, metformin was the most prescribed oral hypoglycemic agent (72.2%), decreasing to 56.67% postoperatively. Intraoperatively, only 1.6% received insulin, while 98.4% received no drugs. Common postoperative antidiabetic agents included insulin BD (n=48). General surgery (73.3%) and orthopedics (26.7%) contributed 132 and 48 patients, respectively, with spinal anesthesia (68.3%) and bupivacaine (75.4%) being most prevalent. Blood glucose during surgery was effectively monitored. Hypertension (52.8%) was the most common co-morbidity, and Ringer lactate (60.8%) was the predominant IV fluid. Conclusions: Adequate perioperative antidiabetic management was observed in hyperglycemic patients.
{"title":"Perioperative management of hyperglycemic patients undergoing surgery: an observational cross sectional study in a tertiary care hospital","authors":"Namra A. Sayed, Yashashri Shetty, S. Salgaonkar","doi":"10.18203/2349-3259.ijct20242000","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242000","url":null,"abstract":"Background: Diabetes poses an additional risk during anesthesia, yet there is a lack of sufficient Indian data on perioperative antidiabetic drug use and its implications. This droves us to conduct the study.\u0000Methods: Cross-sectional, observational study, conducted in a tertiary care hospital's general surgery and orthopaedics wards. Data collected from the first anaesthetist visit to 24 hours postoperative period included antidiabetic medications, anesthesia drugs, blood sugar levels, co-morbidities, concomitant medications, and intravenous (IV) fluids. Descriptive statistics and parametric tests were used for analysis.\u0000Results: The study comprised 180 patients (62.8% males, median age 56 years), with diabetes duration predominantly between 1-5 years (28.3%). Preoperatively, metformin was the most prescribed oral hypoglycemic agent (72.2%), decreasing to 56.67% postoperatively. Intraoperatively, only 1.6% received insulin, while 98.4% received no drugs. Common postoperative antidiabetic agents included insulin BD (n=48). General surgery (73.3%) and orthopedics (26.7%) contributed 132 and 48 patients, respectively, with spinal anesthesia (68.3%) and bupivacaine (75.4%) being most prevalent. Blood glucose during surgery was effectively monitored. Hypertension (52.8%) was the most common co-morbidity, and Ringer lactate (60.8%) was the predominant IV fluid.\u0000Conclusions: Adequate perioperative antidiabetic management was observed in hyperglycemic patients.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"25 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20242005
P. S., Nalini V., Priyanka S., T. J, Subbulakshmi V., Amalraj A., Maheshkumar K.
Background: Aging involves physical, psychological, and social changes, including chronic non-communicable pathologies and HPA axis dysfunction. Yoga can manage these issues, while mind sound resonance technique (MSRT) can alleviate stress, anxiety, and improve psychomotor function. This study aims to report the methodology for three months of MSRT sessions and their impact on physiological and psychological parameters in the geriatric population. Methods: A randomized controlled trial will involve 80 participants aged 60-75 years, divided into an intervention group and a control group. The intervention group will receive 45 minutes of MSRT sessions daily for 90 days, while the control group will not receive any intervention. Post-intervention assessment will be taken and compared with the control group after 90 days. Conclusions: MSRT, having a dual benefit as meditative and relaxation component, has been shown to improve the physiological and psychological well-being of the geriatric population, with expected outcomes including improved cardio-autonomic, pulmonary, neurocognitive, and psychological functions and changes in serum stress markers. Trial registration (CTRI): CTRI/2024/02/062308.
{"title":"Effect of mind sound resonance technique on physiological and psychological parameters among geriatric population: a structured study protocol for a randomized controlled trial","authors":"P. S., Nalini V., Priyanka S., T. J, Subbulakshmi V., Amalraj A., Maheshkumar K.","doi":"10.18203/2349-3259.ijct20242005","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242005","url":null,"abstract":"Background: Aging involves physical, psychological, and social changes, including chronic non-communicable pathologies and HPA axis dysfunction. Yoga can manage these issues, while mind sound resonance technique (MSRT) can alleviate stress, anxiety, and improve psychomotor function. This study aims to report the methodology for three months of MSRT sessions and their impact on physiological and psychological parameters in the geriatric population.\u0000Methods: A randomized controlled trial will involve 80 participants aged 60-75 years, divided into an intervention group and a control group. The intervention group will receive 45 minutes of MSRT sessions daily for 90 days, while the control group will not receive any intervention. Post-intervention assessment will be taken and compared with the control group after 90 days.\u0000Conclusions: MSRT, having a dual benefit as meditative and relaxation component, has been shown to improve the physiological and psychological well-being of the geriatric population, with expected outcomes including improved cardio-autonomic, pulmonary, neurocognitive, and psychological functions and changes in serum stress markers.\u0000Trial registration (CTRI): CTRI/2024/02/062308.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"50 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141805801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20242004
Abirami Manickam, Maheshkumar Kuppusamy, S. T. Venkateswaran, K. S. Lakshmi
Background: Functional near-infrared spectroscopy (fNIRS) is a tool to measure variations in cerebral hemodynamics. The study investigates the physiological changes in cerebral blood flow before, during, and after the practice of bantha hasta utthanasana among healthy participants. Methods: The proposed study is a hospital-based randomized controlled trial comparing bantha hasta utthanasana with the control group. A total of 60 participants will be randomly divided into an intervention group (n=30) and a control group (n=30) as per inclusion and exclusion criteria. The intervention group will practice bantha hasta utthanasana for 10 minutes. The control group will be instructed to sit for 10 minutes. Functional near-infrared spectroscopy will be performed before (5 minutes), during (10 minutes), and after (5 minutes) the practice in both groups. Conclusions: This study protocol aims to investigate whether the practice of bandha hasta utthanasana can enhance cerebral hemodynamics. The research seeks to determine if this simple practice can be used to manage individuals with cerebral hemodynamic impairment and potentially prevent such issues in the future. Trial Registration: CTRI/2023/10/059039.
背景：功能性近红外光谱（fNIRS）是一种测量脑血流动力学变化的工具。本研究调查了健康参与者在练习 bantha hasta utthanasana 之前、期间和之后脑血流的生理变化：拟进行的研究是一项基于医院的随机对照试验，将班达哈达式与对照组进行比较。根据纳入和排除标准，共 60 名参与者将被随机分为干预组（30 人）和对照组（30 人）。干预组将练习 Bantha hasta utthanasana 10 分钟。对照组将被指导静坐 10 分钟。两组分别在练习前（5 分钟）、练习中（10 分钟）和练习后（5 分钟）进行功能性近红外光谱分析：本研究方案旨在调查练习 bandha hasta utthanasana 是否能增强大脑血液动力学。研究旨在确定这种简单的练习是否可用于管理脑血流动力学受损的患者，并有可能在未来预防此类问题的发生：CTRI/2023/10/059039.
{"title":"Immediate effects of bandha hasta utthanasana on cerebral hemodynamics in healthy individuals: a protocol for randomized controlled trial","authors":"Abirami Manickam, Maheshkumar Kuppusamy, S. T. Venkateswaran, K. S. Lakshmi","doi":"10.18203/2349-3259.ijct20242004","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242004","url":null,"abstract":"Background: Functional near-infrared spectroscopy (fNIRS) is a tool to measure variations in cerebral hemodynamics. The study investigates the physiological changes in cerebral blood flow before, during, and after the practice of bantha hasta utthanasana among healthy participants.\u0000Methods: The proposed study is a hospital-based randomized controlled trial comparing bantha hasta utthanasana with the control group. A total of 60 participants will be randomly divided into an intervention group (n=30) and a control group (n=30) as per inclusion and exclusion criteria. The intervention group will practice bantha hasta utthanasana for 10 minutes. The control group will be instructed to sit for 10 minutes. Functional near-infrared spectroscopy will be performed before (5 minutes), during (10 minutes), and after (5 minutes) the practice in both groups.\u0000Conclusions: This study protocol aims to investigate whether the practice of bandha hasta utthanasana can enhance cerebral hemodynamics. The research seeks to determine if this simple practice can be used to manage individuals with cerebral hemodynamic impairment and potentially prevent such issues in the future.\u0000Trial Registration: CTRI/2023/10/059039.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"56 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141804955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The increasing demand for accelerated rehabilitation and shorter hospital stays emphasizes the importance of effective post-surgical skin closure techniques. Orthopaedic and open abdominal surgeries commonly use metal staples or polyamide sutures for wound closure. Surgical site infections (SSIs) remain a significant concern, impacting patient outcomes and healthcare costs. Methods: This prospective, randomized, single-centre trial aimed to compare clinical outcomes in 140 adult patients, randomized between Trupler skin stapler and Trulon polyamide sutures, undergoing orthopaedic and open abdominal surgeries. The primary endpoint was the incidence of SSI according to CDC criteria. Secondary outcomes included wound complications, post-operative pain, patient satisfaction, cosmetic appearance, time taken for closure, ease of use, and safety of the interventions. Results: The primary endpoint did not show any significant difference in the number of SSIs between the two groups. Both groups experienced wound complications, but the stapler group showed less severe outcomes. The stapler group demonstrated improved time efficiency and ease of closure, leading to reduced post-operative pain and higher patient satisfaction. Cosmetic outcomes were superior in the stapler group. Adverse events were reported in both groups, with a slightly higher incidence in the suture group. Conclusions: The Trupler skin stapler demonstrated advantages over Trulon polyamide sutures for wound closure. Despite similar SSI rates, the stapler group experienced improved time efficiency, lower post-operative pain, higher patient satisfaction, and superior cosmetic outcomes. The study supports the preference for Trupler skin stapler for wound closure in orthopaedic and open abdominal surgeries.
{"title":"A randomized clinical study comparing Trupler skin stapler and Trulon polyamide suture in post-surgical skin closure during orthopaedic and open abdominal surgeries","authors":"Debdutta Chatterjee, Nisith Karmakar, Tirna Halder","doi":"10.18203/2349-3259.ijct20242001","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20242001","url":null,"abstract":"Background: The increasing demand for accelerated rehabilitation and shorter hospital stays emphasizes the importance of effective post-surgical skin closure techniques. Orthopaedic and open abdominal surgeries commonly use metal staples or polyamide sutures for wound closure. Surgical site infections (SSIs) remain a significant concern, impacting patient outcomes and healthcare costs.\u0000Methods: This prospective, randomized, single-centre trial aimed to compare clinical outcomes in 140 adult patients, randomized between Trupler skin stapler and Trulon polyamide sutures, undergoing orthopaedic and open abdominal surgeries. The primary endpoint was the incidence of SSI according to CDC criteria. Secondary outcomes included wound complications, post-operative pain, patient satisfaction, cosmetic appearance, time taken for closure, ease of use, and safety of the interventions.\u0000Results: The primary endpoint did not show any significant difference in the number of SSIs between the two groups. Both groups experienced wound complications, but the stapler group showed less severe outcomes. The stapler group demonstrated improved time efficiency and ease of closure, leading to reduced post-operative pain and higher patient satisfaction. Cosmetic outcomes were superior in the stapler group. Adverse events were reported in both groups, with a slightly higher incidence in the suture group.\u0000Conclusions: The Trupler skin stapler demonstrated advantages over Trulon polyamide sutures for wound closure. Despite similar SSI rates, the stapler group experienced improved time efficiency, lower post-operative pain, higher patient satisfaction, and superior cosmetic outcomes. The study supports the preference for Trupler skin stapler for wound closure in orthopaedic and open abdominal surgeries.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141804299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20241997
Stefano Stabile, Veronica Franchina, S. Testoni, F. Mannozzi, Francesca Fabbri, I. Federici, Marta Betti, Francesca Zepponi, A. Frazzetto, Giovanni Micallo, Raffaella Bertolotti, Claudia Sangalli, Celeste Cagnazzo, Oriana Nanni
Background: Post-COVID-19, rapid technological progress enabled remote healthcare interactions, fostering DCT activities. Sponsors and sites adapted by digitizing traditional model, utilizing wearables and home nursing. However, challenges like staff oversight and logistics demand careful evaluation for regulatory compliance. Methods: Italian association of medical oncology's study coordinators working group, in collaboration with Italian group of data managers, conducted an anonymous online survey among Italian oncology professionals. Survey aimed to explore their perceptions of remote patient monitoring, trial activities, and home nursing in oncology clinical trials. Results: Out of 111 professionals (42.3% coordinators, 27.0% physicians, 18.8% nurses), 29.7% lacked prior experience in remote patient data capture, while 61.3% had low or medium experience. On a 0-10 VAS scale, 58.6% found remote modalities very useful, with high scores (8-10) for various remote activities like quality of life data capture (71.2%), vital signs transmission (66.7%), and home nursing tasks (65.8%). Regarding home nursing in oncology clinical trials 73.0% of participants (n=81) have declared no previous experience. However this remote activity is considered highly useful for tasks such as biological samples collection (76.6%), vital signs collection (73.9%), quality of life evaluation (71.2%), and adverse events monitoring (65.8%). Conclusions: Electronic devices for remote data capture are prevalent in oncology trials, positively perceived by a significant portion of staff. Remote data collection correlates with improved workload perception. Although home nursing is less common in Italy, healthcare professionals show a positive perception, indicating potential benefits for clinical trial efficiency and workload improvement.
{"title":"Perception of decentralized clinical trials and home nursing in oncology clinical research: insights from a survey of clinical research professionals across experimental sites","authors":"Stefano Stabile, Veronica Franchina, S. Testoni, F. Mannozzi, Francesca Fabbri, I. Federici, Marta Betti, Francesca Zepponi, A. Frazzetto, Giovanni Micallo, Raffaella Bertolotti, Claudia Sangalli, Celeste Cagnazzo, Oriana Nanni","doi":"10.18203/2349-3259.ijct20241997","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20241997","url":null,"abstract":"Background: Post-COVID-19, rapid technological progress enabled remote healthcare interactions, fostering DCT activities. Sponsors and sites adapted by digitizing traditional model, utilizing wearables and home nursing. However, challenges like staff oversight and logistics demand careful evaluation for regulatory compliance.\u0000Methods: Italian association of medical oncology's study coordinators working group, in collaboration with Italian group of data managers, conducted an anonymous online survey among Italian oncology professionals. Survey aimed to explore their perceptions of remote patient monitoring, trial activities, and home nursing in oncology clinical trials.\u0000Results: Out of 111 professionals (42.3% coordinators, 27.0% physicians, 18.8% nurses), 29.7% lacked prior experience in remote patient data capture, while 61.3% had low or medium experience. On a 0-10 VAS scale, 58.6% found remote modalities very useful, with high scores (8-10) for various remote activities like quality of life data capture (71.2%), vital signs transmission (66.7%), and home nursing tasks (65.8%). Regarding home nursing in oncology clinical trials 73.0% of participants (n=81) have declared no previous experience. However this remote activity is considered highly useful for tasks such as biological samples collection (76.6%), vital signs collection (73.9%), quality of life evaluation (71.2%), and adverse events monitoring (65.8%).\u0000Conclusions: Electronic devices for remote data capture are prevalent in oncology trials, positively perceived by a significant portion of staff. Remote data collection correlates with improved workload perception. Although home nursing is less common in Italy, healthcare professionals show a positive perception, indicating potential benefits for clinical trial efficiency and workload improvement.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"39 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141804057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.18203/2349-3259.ijct20241999
Yashashri Shetty, Padmaja Marathe, Manasi Lad, Prajakta D. Auti, J. Katkar, Vishal Singh
Background: An e-EC software (Create 4) was introduced since past 4 years at few institutional ethics committees (EC) in India. The software provided facilities for submission, online review and communication between investigator and EC. The study was to assess the perception of different stakeholders: investigators, chairperson, member secretary (MS), EC members, administrative staff regarding their experiences of using software, challenges faced and recommendations for improvisation. Methods: Following approval of the institutional EC, the participants were enrolled after obtaining their written informed consent. The questionnaires specifically designed and validated for each category of investigators, EC members and administrative staff were administered. Strict confidentiality was maintained. The data was analysed using descriptive statistics. Results: A total of 64 stakeholders who participated, there were 34 investigators, 18 EC members, 2 Chairpersons, 4 member secretaries, 6 administrative staff. The e-software was accepted well by majority of the stakeholders. Overall, the software was found to be user-friendly. A few challenges faced were: lack of adequate training for investigators and new EC members, inconvenience faced while downloading study documents one by one and the need to ensure uninterrupted internet access at workplace. The user ECs should ensure that the investigators and EC members are tech-savvy and they receive prior training. It was suggested that there needs to be an autofill option built-in while uploading document/s. Conclusions: E-software was found to be useful by the stakeholders and provided suggestions to optimize its us.
{"title":"Perception of ethics committee members and investigators on implementation of e-EC software for ethics committees","authors":"Yashashri Shetty, Padmaja Marathe, Manasi Lad, Prajakta D. Auti, J. Katkar, Vishal Singh","doi":"10.18203/2349-3259.ijct20241999","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20241999","url":null,"abstract":"Background: An e-EC software (Create 4) was introduced since past 4 years at few institutional ethics committees (EC) in India. The software provided facilities for submission, online review and communication between investigator and EC. The study was to assess the perception of different stakeholders: investigators, chairperson, member secretary (MS), EC members, administrative staff regarding their experiences of using software, challenges faced and recommendations for improvisation.\u0000Methods: Following approval of the institutional EC, the participants were enrolled after obtaining their written informed consent. The questionnaires specifically designed and validated for each category of investigators, EC members and administrative staff were administered. Strict confidentiality was maintained. The data was analysed using descriptive statistics.\u0000Results: A total of 64 stakeholders who participated, there were 34 investigators, 18 EC members, 2 Chairpersons, 4 member secretaries, 6 administrative staff. The e-software was accepted well by majority of the stakeholders. Overall, the software was found to be user-friendly. A few challenges faced were: lack of adequate training for investigators and new EC members, inconvenience faced while downloading study documents one by one and the need to ensure uninterrupted internet access at workplace. The user ECs should ensure that the investigators and EC members are tech-savvy and they receive prior training. It was suggested that there needs to be an autofill option built-in while uploading document/s.\u0000Conclusions: E-software was found to be useful by the stakeholders and provided suggestions to optimize its us.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"39 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141805301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-24DOI: 10.18203/2349-3259.ijct20240967
Melanie L. Paglione
Have you ever wondered, what does a clinical research nurse (CRNs) do from day-to-day or week-to-week? This article will attempt to answer those questions by including what defines research, clinical research and a CRN. Topics will also include the roles in which CRNs are responsible for or can complete, the challenges they face and their importance in clinical trials. In additional, advantages of being a CRN will be reviewed and how this can powerfully change your view on the career and then stories from CRNs at two major academic research institutes will be reported and how lives are changed because of research nurses. If you read this article and determine that this path may be what you want to pursue or learn more about, the writer has included a section about training and certification which can be reviewed and explored. Also included is knowledge which is helpful to learn when exploring this topic.
{"title":"A day in the life of a clinical research nurse","authors":"Melanie L. Paglione","doi":"10.18203/2349-3259.ijct20240967","DOIUrl":"https://doi.org/10.18203/2349-3259.ijct20240967","url":null,"abstract":"Have you ever wondered, what does a clinical research nurse (CRNs) do from day-to-day or week-to-week? This article will attempt to answer those questions by including what defines research, clinical research and a CRN. Topics will also include the roles in which CRNs are responsible for or can complete, the challenges they face and their importance in clinical trials. In additional, advantages of being a CRN will be reviewed and how this can powerfully change your view on the career and then stories from CRNs at two major academic research institutes will be reported and how lives are changed because of research nurses. If you read this article and determine that this path may be what you want to pursue or learn more about, the writer has included a section about training and certification which can be reviewed and explored. Also included is knowledge which is helpful to learn when exploring this topic.","PeriodicalId":13787,"journal":{"name":"International Journal of Clinical Trials","volume":"58 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140661790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：